Abdlkadir, Ahmed SaadAl-Adhami, DhuhaShi, HongchengSathekge, Mike MachabaSheikha, Areej AbuMohamad, IssaKreissl, MichaelAl-Ibraheem, Akram2026-03-092026-03-092026-02Abdlkadir, A.S., Al-Adhami, D., Shi, H. et al. Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis. Thyroid Research 19, 7: 1-10 (2026). https://doi.org/10.1186/s13044-026-00290-x.1756-6614 (online)10.1186/s13044-026-00290-xhttp://hdl.handle.net/2263/108834DATA AVAILABILITY : The current study data are available from the corresponding author on reasonable request.Please read abstract in the article.en© The Author(s) 2026. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.Peptide receptor radionuclide therapy (PRRT)Somatostatin receptor (SSTR)Medullary thyroid cancer (MTC)Medullary thyroid carcinomaTargeted radionuclide therapy[177Lu]Lu-DOTATATE[90Y]Y-DOTATOCArticle